Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 13,950
+60 (0.43%)
At close: Jul 9, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 32.13 billion as of July 10, 2026. Its market cap has increased by 37.38% in one year.
Market Cap
32.13B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,950.00
Market Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 32.13B, a decrease of -45.15%. That is a compound annual growth rate of -18.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 32.13B | -7.13% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psomagen | 52.80B |
| J2KBIO | 45.26B |
| Parataxis Korea | 44.13B |
| HLB Pep | 43.88B |
| Progen | 43.51B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Quratis | 32.62B |